Awards & Grants

Portrait Anette Gabriele Ziegler, Querformat;

Prof. Anette-Gabriele Ziegler from Helmholtz Munich has been named the recipient of the 58th Claude Bernard Prize, the highest honor awarded by the European Association for the Study of Diabetes (EASD). The prize recognizes her outstanding leadership…

Physician and researcher Prof. Antje Körner has been elected as a new member of the Saxon Academy of Sciences and Humanities in Leipzig. On April 10, 2026, she was officially admitted to the Academy’s Mathematical and Natural Sciences Class during…

Porträt Marcus Conrad
Hochformat
Background: HDC Indoor

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

The American Diabetes Association (ADA) has announced the recipients of this year's National Scientific and Health Care Achievement Awards. Among this year’s awardees is Prof. Timo Müller, Director of the Institute for Diabetes and Obesity (IDO) at…

Fabian Theis bei Eröffnung des Google AI Centers Berlin

On March 5, Google opened its first German AI Center in Berlin. The event was attended by representatives from politics, business, and science, including Federal Research Minister Dorothee Bär, Federal Digital Minister Karsten Wildberger, Berlin's…

Helmholtz Munich has been awarded a prestigious grant of up to 900 000 US Dollar from Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization. The funding will support the research into early-stage T1D in adults,…

Awards & Grants

News

Anette-Gabriele Ziegler Receives Claude Bernard Prize for Diabetes Research

Antje Körner Elected to the Saxon Academy of Sciences and Humanities in Leipzig

Marcus Conrad Receives German Cancer Award 2026

Timo Müller Receives the ADA 2026 Outstanding Scientific Achievement Award

Google Opens AI Center in Berlin and Supports AI Projects by Fabian Theis

Helmholtz Munich Secures Funding to Investigate Early-Stage Type 1 Diabetes in Adults